PHIEGO PHARMA

Active

Private limited companyfounded 20206 yrs activeRijselstraat 94, 8900 Ieper, BelgiumKBO/BCE: BE 0742.531.238

PHIEGO PHARMA has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €101k and a net result of €13k. Equity is growing by ~16% per year across the filed fiscal years. Its solvency ranks better than 24% of 37960 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.4% (very low).

Watch Print / PDF

Checked score

Score 2024

67 / 100

Healthy

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2023

Profitability71▼-9

Solvency50▲+5

Growth52▼-26

Track record100

Bankruptcy probability, 12 months

0.4% Very low

0%0.5%1.5%4%10%≥ 25%

Credit up to €6k at 30 days acceptable

Liquidity short (current ratio 0.97 against 0.96 in 2023; short-term debt: 8.8% and cash: 3.4% of total assets), and 74.9% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 70

Relative position

BE, all sectors

reference

Sector 70

lower

← fewer bankruptcies more bankruptcies →

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

Annual accounts: weaker financial profile

The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.

NBB · annual accounts 2024

Solvency, return and age of the figures

Solvency

25.1%

Return on assets

3.1%

Age of the figures

21 mo

Weak solvency vs sector

Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 37960 sector peers (2024).

NBB · sector comparison

Position among 37960 sector peers

Solvency

better than 24%

← weakest strongest →

Latest accounts filed on time

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 01-07-2025, 30 days ahead of the deadline.

NBB · 5 filings

Deviation from the deadline

2025

not confirmed

2024

30 d early

2023

140 d early

2022

154 d early

2021

139 d early

2020

145 d early

← before the deadline after the deadline →

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity

€101k▲ 14.2%

2023 · €89k

2020: €39k 2021: €64k 2022: €88k 2023: €89k

2020 → 2024

Total assets

€404k▼ 8.8%

2023 · €443k

2020: €66k 2021: €438k 2022: €439k 2023: €443k

2020 → 2024

Net result

€13k▼ 68.8%

2023 · €40k

2020: €34k 2021: €25k 2022: €25k 2023: €40k

2020 → 2024

Working capital

€-1k▲ 51.6%

2023 · €-2k

2020: €31k 2021: €-9k 2022: €1k 2023: €-2k

2020 → 2024

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20202021202220232024Trend

Equity€39k-€64k▲ 65.1%€88k▲ 38.9%€89k▲ 0.5%€101k▲ 14.2%

Operating result€45k-€37k▼ 15.9%€40k▲ 7.0%€59k▲ 46.7%€26k▼ 56.5%

Net result€34k-€25k▼ 25.2%€25k▼ 1.2%€40k▲ 63.0%€13k▼ 68.8%

Turnover and EBIT margin not published: the micro schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result falls in 2024; 2024 is 57% below 2023 and is the lowest result in the available series.

Balance-sheet composition

2024 in colour, 2023 as the grey bar beneath

Assets €404k

91.5%

Fixed assets €369k▼ 4.1%

Current assets €34k▼ 40.2%

Equity and liabilities €404k

25.1%

74.9%

Equity €101k▲ 14.2%

Debt €302k▼ 14.6%

The debt ratio falls from 79.9% to 74.9%. Equity is higher and debt is lower.

Key figures and ratios

2024 value · change against 2023

EBITDA

€42k▼

2023 · €75k

Cash flow

€29k▼

2023 · €56k

Solvency

25.1%▲

2023 · 20.1%

Current ratio

0.97▲

2023 · 0.96

Quick ratio

0.97▲

2023 · 0.96

Debt / equity

2.98▼

2023 · 3.98

ROE

12.4%▼

2023 · 45.5%

ROA

3.1%▼

2023 · 9.1%

Interest coverage

5.75▼

2023 · 15.52

Debt

€302k▼

2023 · €354k

Debt ≤ 1 year

€35k▼

2023 · €60k

Debt > 1 year

€267k▼

2023 · €294k

Income taxes

€6k▼

2023 · €14k

Staff costs

€2k▲

2023 · €2k

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2024 against 2023

Balance sheet Code20232024

Assets

Total assets20/58€443k€404k▼

Fixed assets21/28€385k€369k▼

Tangible fixed assets22/27€385k€369k▼

Land and buildings22€383k€368k▼

Furniture and vehicles24€2k€1k▼

Current assets29/58€58k€34k▼

Amounts receivable within one year40/41€21k€18k▼

Trade receivables40€21k€11k▼

Other amounts receivable41€4€7k▲

Cash at bank and in hand54/58€34k€14k▼

Deferred charges and accrued income490/1€3k€3k▲

Equity and liabilities

Total equity and liabilities10/49€443k€404k▼

Equity10/15€89k€101k▲

Contributions10/11€5k€5k=

Reserves13€84k€96k▲

Distributable reserves133€84k€96k▲

Amounts payable17/49€354k€302k▼

Amounts payable after more than one year17€294k€267k▼

Financial debts170/4€294k€267k▼

Amounts payable within one year42/48€60k€35k▼

Current portion of amounts payable after more than one year42€27k€27k▲

Trade debts44€1k€496▼

Suppliers440/4€1k€496▼

Taxes, remuneration and social security45€15k€8k▼

Taxes450/3€15k€8k▼

Other amounts payable47/48€17k-

Income statement Code20232024

Remuneration, social security and pensions62€2k€2k▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€16k€17k▲

Other operating charges640/8€5k€3k▼

Non-recurring operating charges66A€4k-

Gross operating margin9900€85k€47k▼

Operating profit (loss)9901€59k€26k▼

Financial income75/76B-€16

Recurring financial income75-€16

Financial charges65/66B€5k€7k▲

Recurring financial charges65€5k€7k▲

Profit (loss) for the period before taxes9903€54k€18k▼

Income taxes67/77€14k€6k▼

Profit (loss) for the period9904€40k€13k▼

Profit (loss) for the period to be appropriated9905€40k€13k▼

Appropriation of the result

Profit (loss) to be appropriated9906€40k€13k▼

Transfer from equity791/2€20k-

Transfer to equity691/2€20k€13k▼

To other reserves6921€20k€13k▼

Profit to be distributed694/7€40k-

Return on contributions (dividend)694€40k-

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 8Financial 3Filings 5

2025

01-07

NBB filing Annual accounts filed

fiscal year 2024 · micro schema

2024

31-12

Financial Weakest financial yearnet €13k ▼68.8%

Net result drops to €13k, the lowest in the series.

31-12

Financial Equity above €100kEq €101k ▲14.2%

5 profitable years in a row build equity to €101k.

13-03

NBB filing Annual accounts filed

fiscal year 2023 · micro schema

2023

31-12

Financial Highest result since 2020net €40k ▲63%

Operating result €59k, net result €40k, both a record.

27-02

NBB filing Annual accounts filed

fiscal year 2022 · micro schema

2022

14-03

NBB filing Annual accounts filed

fiscal year 2021 · micro schema

2021

08-03

NBB filing Annual accounts filed

fiscal year 2020 · micro schema

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.

Location & real-estate footprint

Registered office, Ieper · 1 establishment unit since 2020

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rijselstraat 948900 Ieper

Ground area

184 m²

Building footprint

96 m²

Volume, LiDAR

649 m³

Parcel 33011I0332/00N000, Flanders · tallest building 12.1 m, ±2 floors. Linked by address, not a title deed.

1 establishment unit

PHIEGO PHARMA

Rijselstraat 94, 8900 IeperIT consultancy

since 20202.298.338.982

1 parcel

Flanders 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
33011I0332/00N000	Flanders	184 m²	1 · 96 m²	12.1 m · 2 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

HERACON

BE 0474.396.514

Tongeren-Borgloon · Eq €101k

Watermaal-Bosvoorde · Eq €101k

BE 1003.886.949

Chièvres · Eq €101k

Of 82,554 companies in sector 70200 we hold annual accounts for 52,573. 40,606 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification

Legal formPrivate limited company

Founded27-01-2020

Fiscal year end31-12

Activities, NACEBEL

70200Business and other management consultancy

70220Business consulting

62020IT consultancy

62200Computer consultancy and computer facilities management

64200Holdings

64210Activities of holding companies

71209Other technical testing and analysis

73200Market research and public opinion polling

Sources

Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers

Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.